Navigate the cannabis that are fast-moving with 420 Investor, a premium service that sends real-time alerts and explanations of the news below and much more.
- A big acquisition helped fuel gains this
- Cannabis week product sales styles enhanced in
Health december Canada added 7 licenses.
420 Investor model portfolios have gained 61.7-80.9% year-to-date, while the Global Cannabis Stock Index has gained 58.2%.
February began with a extension that is massive of January stock gains. A catalyst that is leading the long-awaited entry of Big Pharma into the cannabis industry, with Jazz Pharmaceuticals announcing its pending acquisition of GW Pharma. Illinois cannabis sales were flat from December, with adult-use up 2% but medical down 5% january. When compared with a ago, combined sales grew 94% year. BDSA data indicated that year-over-year growth accelerated in 8 markets during December after a slowdown that is sharp November. Virginia took one step nearer to adult-use legalization since the homely house approved a bill.
- Health Canada added 7 new licenses this week, leaving the total, the suspended license of Ten-10 Ventures, at 598, which excludes the revoked licenses of Agrima, Alberta Green Biotech, Bloomera, Hexo’s site that is 4th Maricann’s second website, Medican Organic’s second website and a tiny processing center that belonged to Canopy development, the revoked licenses of BC Tweed (2), FV Pharma and Zenalytics Laboratories, the expired licenses of Evergreen Medicinals and Toronto analysis Chemicals, two transferred licenses held previously by James Wagner, a license formerly held by complete Cannabis possibilities plus the voluntarily cancelled permit of Avalite Sciences.
- During The week, I shared these insights with subscribers at 420 Investor:
- Earnings Previews for Three Canadian LPs Reporting Next Week
Why MSOS Is Not the way that is best to Invest in MSOs
- Scotts Miracle-Gro FY21-Q1 Earnings Preview
- Cannabis Sub-Sector Review – 01/29/21
- Model Portfolio Composition 01/29/21
- Here are some of this week’s highlights for 420 Investor Focus List names:
- CCHWF received 5 dispensary permits in West Virginia, where it had already won cultivation and processing licenses.
- CGC unveiled its SurityPro CBD products for dogs
- CRLBF launched adult-use sales in its Phoenix dispensary
- CURLF opened its 34th Florida dispensary
- FFLWF reached 200K members in its Sparks Perks loyalty program
- FLOOF made its delinquent interest payments on its convertible notes
- GNLN will be opening three accessory that is retail in Uruguay through a partnership
- GRWG acquired two shops in Maine
- GTBIF exposed a dispensary in Erie, Pennsylvania, its 52nd as a whole.
- OGI saw its SVP, Operations, a employee that is long-time announce his pending departure
- SHWZ repriced all of its options to $1.26. It also closed on two additional Star Buds locations, paying $9.3 million that was raised through the sale of preferred stock to a group led by its CEO.
SMG reported a very q1 that is strong driven by 71% development in its Hawthorne company and its own core company up 147%. The business raised its income perspective but kept its EPS guidance of $8-8.40 that is intact
TCNNF which already had a processing license in West Virginia, added four permits that are dispensaryand its own recently obtained Solevo health won three). It filed a C$750 million base rack. Furthermore, its S-1 registering shares of current holders went effective. The business started Blue that is offering River Cure Live Rosin in Florida.
TLRY became the cannabis that is first authorized to deliver services and products to clients in Portugal. It made its export that is first from to Spain.
VFF launched gummies
The Global Cannabis Stock Index
soared after having consolidated early-in-the-year gains over the past two weeks, increasing 23.9% to 70.24:
The index, which lost 34.1% in 2019 and lost 54.9% in 2018 after gaining 91.8% in 2017 and 88.8% in 2016, was up 5.2% in 2020. It has gained 58.2% in 2021 thus far. The index currently includes 38 stocks and ended 2020 at 44.39:
420 Investor offers three model portfolios for subscribers, including two that are long-term focused and fully invested with a goal of beating the Global Cannabis Stock Index, 420 Opportunity and 420 Quality. 420 Opportunity ended the valued at $176,640, up 28.5% week. The model profile, up 67.6% in 2021, gained 35.6per cent in 2020 and contains increased 253.3% since 2014 april. 420 Quality ended the at $261,179, up 25.8% for the week and is now up 61.7% in 2021 after gaining 42.8% in 2020 week. The model premiered in March 2017 focusing on investors that are long-term to invest in leading cannabis stocks with low portfolio turnover and has gained 422.4% since inception compared to the 13.1% decrease in the index. Flying High, which is focused on swing trades, ended the valued at $456,554, up 30.3% week. The model profile gained 52.7per cent in 2020 and it is up 80.9% in 2021, plus the return since inception in late 2013 was 4466%.
Related Information:(*)GW Pharma become obtained for $220 Per Share(*)Hawthorne Gardening Q1 Revenue Grows 71% to $309 million(*)Global Cannabis Stocks Extend Torrid Rally in with 28% Gain(*)Cresco Labs to Launch Adult-use Sales at Sunnyside Dispensary in Phoenix, Arizona(* january)